Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
good time to accumulate
yes this will go ballistic at some point soon, good time to accumulate
And indeed, it will be a great year. early buyers here will kill it.
Gala Pharmaceuticals Sees 2018 as Breakthrough Year for Company
2018-01-24 10:47 ET - News Release
anaheim, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Gala Pharmaceuticals Sees 2018 as Breakthrough Year for Company
ANAHEIM, Calif., Jan. 21, 2018 Gala Pharmaceuticals Inc. (GPI) (OTCBB:GLPH) today announced that it is focusing on key 2018 goals to drive success and build long-term shareholder value.
Gala Pharmaceuticals, in 2017, had streamlined its business model, did research and development of key plant species, cloning technologies and strengthened of its management team, all of which laid the foundation for 2018.
Gala Pharmaceuticals believes the following goals, if achieved, will allow the company to consistently grow its market share in high margin, high profit market segments, thus solidifying the company’s position as one of the most innovative companies in the marketplace, which should ultimately increase shareholder value:
Goal #1: Breeding, Tissue Culture and Cloning and High Throughput Testing: GPI is focusing on the development of innovative breeding and cultural tools for growing crops, vegetables and other high value plant species. The company is looking forward to developing high throughput screening technologies for chemical, plant, soil, and liquid composition analysis which will allow assay development for key compositional traits and provide quality services to various customers in agricultural industry.
Goal #2: GPI Genetic Fingerprinting
GPI is also focusing on providing genetic “fingerprinting” and “sequencing” of various crop species in 2018. In doing so, it will be able to develop and store genetic fingerprint information into a proprietary database. GPI customers will then have exclusive access to genetic fingerprint data which can be used for predictive breeding applications and for protecting intellectual property (IP).
Goal #3: Drug Formulations
The company is laying the groundwork to focus on drug formulation processes. The company is expecting to provide oversight for the development of fully Good Manufacturing Practices c(GMP), and production of Active Pharmaceutical Ingredients (API) for use in clinical trials required to support the safety and efficacy of potential drugs for the treatments of various medical conditions.
It is believed that the investments made last year, with a focus on building our genomics technologies as well as our plant cloning techniques, will prove to be two of the greatest factors differentiating us from our competitors in the agriculture industry. “I am extremely excited about the future at Gala Pharmaceuticals, beginning with our expectation to achieve the three initial goals just mentioned,” said Gala Pharmaceuticals CEO, Maqsood Rehman.
Gala Pharmaceuticals is looking forward to leading the development of innovative tools to improve yield and quality for various plant species this year and the company believes it has the right team in place to ensure success. Throughout the course of the year. The company will continue to provide quarterly progress reports so that shareholders may measure company’s performance against the objectives set out in previous shareholder communications. This transparency should elicit further confidence in company’s business model and trust in the Company
Nice to see you here Canna!
I’m here! I’m already “Bulls Deep”...
Morning longs- should be a good week for Gala, maybe news soon?
good close today longs! zero selloff here :D
nice close up 8%, grab shares now while cheap. news will send this thing straight up.
following this board, picked up shares earlier today. this is another undervalued cashflow situation in progress. always a buy.
Hello all- buy now while cheap => hold. really.
Goal #3: Drug Formulations
The company is laying the groundwork to focus on drug formulation processes. The company is expecting to provide oversight for the development of fully Good Manufacturing Practices c(GMP), and production of Active Pharmaceutical Ingredients (API) for use in clinical trials required to support the safety and efficacy of potential drugs for the treatments of various medical conditions.
It is believed that the investments made last year, with a focus on building our genomics technologies as well as our plant cloning techniques, will prove to be two of the greatest factors differentiating us from our competitors in the agriculture industry. “I am extremely excited about the future at Gala Pharmaceuticals, beginning with our expectation to achieve the three initial goals just mentioned,” said Gala Pharmaceuticals CEO, Maqsood Rehman.
Goal #2: GPI Genetic Fingerprinting
GPI is also focusing on providing genetic “fingerprinting” and “sequencing” of various crop species in 2018. In doing so, it will be able to develop and store genetic fingerprint information into a proprietary database. GPI customers will then have exclusive access to genetic fingerprint data which can be used for predictive breeding applications and for protecting intellectual property (IP).
Goal #1: Breeding, Tissue Culture and Cloning and High Throughput Testing: GPI is focusing on the development of innovative breeding and cultural tools for growing crops, vegetables and other high value plant species. The company is looking forward to developing high throughput screening technologies for chemical, plant, soil, and liquid composition analysis which will allow assay development for key compositional traits and provide quality services to various customers in agricultural industry.
Looks like it. Someone selling
Nevada has canceled several pot licenses in recent days.
Are these morons really going to dump this back to a penny
WATCH OUT ON THIS ONE !!! BIG WALL OF PAPER COMING
Believe me you can buy this cheaper
Gala Global Inc., GLAG, changed to Gala Pharmaceutical Inc., GLPH:
http://otce.finra.org/DLSymbolNameChanges
Name change goes into affect Jan 29th, hope we get some updates right after
Great info! Kinda surprised buying hasn't started for GLAG, as low as the float is right now it wouldn't take much to get it moving.
$GRNH & $GLAG DD:
$GRNH We have several million dollar deals waiting for 2018, which will push the PPS higher than our last 2016 MJ mania run. Keep in mind that we are still 4 trading days away from the beginning of our upcoming catalyst, January 1, 2018. We have seen some massive accumulation of shares these few days. PPS is already over 50% from its 52 week low. Also keep in mind that the media hasn’t even begun to focus their attention on the marijuana industry here in California.
(GRNH is headquartered in California)
Further, let’s not forget that we may have more MJ catalysts next year. 2nd catalyst, New Jersey Governor Phil Murphy plans to legalize recreational marijuana within 100 days of taking office. 3rd catalyst, Florida, Arizona, Michigan, & Ohio along with several other states might be going MJ recreational November 2018. And it appears that GRNH has more than just a foothold in the door in Ohio.
After that being said, coupled with the chance that bitcoin profits might be pouring into MJ stocks, marijuana protection bill recently extended, & GRNH being on the list to be part of the ETF, makes me believe that we may have the perfect storm brewing here.
Below are a few factors, projects, and some large dollar deals that I researched before making GRNH my gem pick for the 2018 MJ mania run.
Construction on the 254,528 sq. ft. photovoltaic (PV), solar-powered Greengro Technologies greenhouse, is expected to begin in the third quarter of 2018. The project will use Greengro Technologies’ subsidiary Biodynamics' fully automated off-grid greenhouse technology to cultivate hydroponic vegetables in a controlled environment agriculture (CEA) system.
It’s actually at least the third project Greengro is developing in Ohio. Already it’s got a $25 million project with Global Renewable Resources (GRR) in Shaker Heights, Ohio. Land for the project was committed by The City of Warren, Ohio.
"The backers of this project are not shy about their intentions to confront the disturbing trend of population decline in this region," said Warren Mayor William Franklin. "With careful attention paid to the realities of our current commercial environment, this project helps to inject new opportunities in the community because it has the capability to create exceptional produce and services for a growing market. I support this development and look forward to working with GRR to realize the full potential of this project through land assembly and other supports."
Greengro also has completed project planning for the Foodraiser Project in Columbus, Ohio. Now Foodraiser has to respond with a timeline for the completion of land acquisition and financing.
https://www.solarreviews.com/news/gh-farms-takes-agriculture-indoors-5-acre-greenhouse-071117/
GRNH partnership with Cannabrands AG.
“The two companies will first initiate their European Franchising Model in Germany.”
According to the agreement, Cannabrands will facilitate the marketing efforts needed to engage qualified students for the USA Cannabis Student Immersion “study-abroad” program. Cannabrands will also be responsible for selecting the appropriate European locations for opening Vertical Hydrogarden storefront franchises.
This is after MJ legalization in Germany, which went into effect March 2017. They might be finishing up in Germany & getting ready to start up here in the US.
https://verticalhydrogarden.com/greengro-technologies-and-cannabrands-ag-joint-venture-launches-vertical-hydrogarden-europe/
GRNH working with actual scientists.
“Greengro Technologies Inc. (OTCMKTS:GRNH) has signed an agreement for the formation of a joint venture with Maqsood Rehman, a renowned plant geneticist. The joint venture is for the development, patenting, and licensing of various cannabis strains.
Joint Venture Formation
Greengro Technologies Inc. (OTCMKTS:GRNH)’s subsidiary, GenoBreeding will own 60% of the Joint Venture with the remaining 40% going to Mr. Rehman. The signing of the agreement comes on the heels of GenoBreeding signing an agreement for its first customer, igot420.”
(“igot420” North Hollywood location is open for business & Cathedral City location is coming soon)
“The Joint Venture’s business plan will rely on advanced technologies including breeding methods and genome sequencing to come up with cannabis strains.”
“The Company is confident its proprietary combination and utilization of these tools, under the painstaking direction of one of the nation’s best-qualified plant geneticists, will yield valuable new strains of cannabis and push the edge of the technology to new levels of science. His team includes two master cannabis growers and a molecular genetics and data development scientist,” said Greengro Technologies Inc. (OTCMKTS:GRNH) in a statement.”
“GenoBreeding will patent any strains that are created as a result of the partnership. In addition to selling cannabis strains, the company also plans to license them to other companies such as igot420.”
“The company’s commercialization plan will target growers, producers, and dispensaries looking to develop marijuana strains. Greengro Technologies Inc. (OTCMKTS:GRNH) also plans to target biotech firms planning to conduct cannabis-related clinical research trials.”
Rehman Appointment
“In addition to forming a joint venture, GreenGro Technologies has appointed Dr. Rehman as the Chief Operating Officer. He joins the company with vast experience and a diverse background in working with large public and private companies in the field of genetics.”
“Dr. Rehman will lead Greengro Technologies Inc. (OTCMKTS:GRNH) Gala Global development team. The team is currently commercializing digital plant cloning incubators from Controlled Environment Genomics.”
(Manufacturing to start December 2017 & distribution January 2018)
https://globenewswire.com/news-release/2017/09/21/1125972/0/en/Gala-Global-to-Begin-Sales-and-Distribution-of-Its-Plant-Cloning-Incubators-to-Colorado-Market.html
“We welcome Dr. Rehman as he brings with him a diverse background of working with large public and private companies in the field of genetics and the commercialization of genetically modified crops for a wide variety of uses,” said Gala Global CEO, Timothy Madden.”
(Dr. Rehman now shows as CEO of GLAG and Timothy Madden as COO of GRNH)
$4 Million Financing
“Separately, the provider of eco-friendly green horticulture technologies has secured $4 million in financing. The money is to be used to build a second igot420 dispensary in Cathedral City. Greengro Technologies Inc. (OTCMKTS:GRNH) has already received $2 million of the financing with the remaining $2 million set to be drawn pending project advancement.”
http://stocknewsunion.com/tag/greengro-technologies-inc-otcmktsgrnh/
Here’s a little background on Dr Rehman.
“Dr. Maqsood Rehman, is currently CEO of Gala Global, Inc. ("GLAG") where he was the COO since June 2017. Prior to GLAG, Dr. Rehman was the Global Soybean Breeding Leader for Dow Agrosciences at Indianapolis, Indiana for six years. Previously, he worked as a soybean breeder for Monsanto Company at Oxford, Indiana for five years. Dr. Rehman has Masters and PhD degrees in Plant Science from University of Idaho, U.S.A. and Post Doctorate from University of Missouri-Columbia, Missouri. Dr. Rehman also has a diversified scientific background with training, and 10 plus years of practical experience in plant breeding, quantitative and molecular genetics and cytogenetics and project
management.
Dr. Rehman's experience ranges from providing leadership to the breeding
organization to developing breeding strategies and budgets needed to accomplish breeding goals. He fills in the gaps by bringing key stakeholders together and aligns breeding goals with global commercial needs through effective communication. Dr. Rehman is also an expert at developing teams and providing
effective and transparent communication process to achieve deliverables.
http://m.4-traders.com/GALA-GLOBAL-INC-18044897/news/GALA-GLOBAL-INC-Change-in-Directors-or-Principal-Officers-Other-Events-form-8-K-25590078/
Further, the company is also working with Dr Katrina Cornish in Ohio.
https://globenewswire.com/news-release/2017/10/05/1141385/0/en/Gala-Global-Inc-Subsidiary-Controlled-Environment-Genomics-Inc-Partners-with-Dr-Katrina-Cornish-To-Apply-To-The-Ohio-State-University-Industrial-SEED-Grant-Partnership-Program-Thro.html
GLAG has their Facebook to direct investors to the GRNH website? “For Investor information, please visit: http://greengrotech.com/investors/“
https://m.facebook.com/galaglobalinc/about/?ref=page_internal&mt_nav=1
Cannabis Ventures Inc is a wholly owned subsidiary of GLAG. Signed on with GRNH to provide all equipment and design services for its grow facilities.
https://cannabisventuresinc.com/investors/
Cannabis Ventures Inc has their email as greengrotech@gmail.com on FB?
https://m.facebook.com/Cannabis-Ventures-Inc-1374412469510671/about/?ref=page_internal&mt_nav=1
Cannabis Ventures Glass Greenhouse Franchises
ANAHEIM, CA (Marketwire – March 2, 2017) – Greengro Technologies, Inc. (OTC: GRNH), a world-class provider of eco-friendly green technologies, has announced that the company signed a 40-year lease to develop a 4.5-acre property as part of a Cannabis Ventures Inc. (a subsidiary of Gala Global Inc. (OTC: GLAG ), cultivation franchise in Adelanto, Calif., a San Bernardino County community with commercial regulations for large-scale cannabis growing and harvesting.
Greengro’s is basing the deal on its “3-Tier Franchise Model” designed for businesses in the field of controlled environment agriculture (CEA). The three tiers are: 1) Glass Vegetable Greenhouse Franchises, 2) Glass Cannabis Ventures Inc. Franchises / Cannabis Sector, and 3) Vertical Hydrogarden Stores.
Greengro’s second tier Cannabis Ventures Glass Greenhouse Franchises / Cannabis Sector provide customers with the company’s signature Glass Greenhouses under the Cannabis Ventures brand for the cultivation of recreational and medical cannabis.
Gala Global Inc.’s subsidiary, Cannabis Ventures, is a developer of leading scientific processes for cultivating bio-medical grade cannabis plants featuring a higher concentration of cannabidiol (CBD), a cannabis compound known for its significant medical benefits.
“A Cannabis Ventures glass greenhouse franchise resolves upfront all of an indoor grow operation’s startup challenges, in particular taking the difficulty and complexity out of regulatory compliance in the state of California,” said James Haas, CEO of Greengro Technologies.
Greengro’s Adelanto cannabis grow facilities lease agreement covers 20 years, with two 10-year renewal options for $1,200 annually. Under the terms of the agreement, Greengro will obtain financing for its tenants to build at least two 22,000-sq.-ft. photovoltaic (PV) solar glass greenhouses featuring four-level vertical systems able to produce up to 575 lbs. of cannabis per week. Two of the facilities will be used for plant cultivation and the third as a modular CO2 extraction laboratory. Greengro will receive revenues from three areas: turnkey lease rent, nutrients, supplies and consulting services. Along with financing, the Cannabis Ventures Glass Greenhouse Franchise provides the growers with other benefits that include regulatory compliance, initial system planning and design and operational support and training.
“Adelanto is a perfect fit for Greengro and our customers because it has committed to authorizing up to six cannabis growing warehouses to operate in the city’s five industrial parks,” said Haas. “Adelanto has already approved 43 permits across four cannabis-growing activities. Our turnkey cannabis greenhouse facilities will furnish high capacity growers with top-of-the-line, fully automated hydroponic technology for commercial-level cannabis production.”
Greengro’s 22,000-sq.-ft. solar glass greenhouses are precisely constructed to facilitate industrial cannabis cultivation and harvesting requirements, Haas said. Each greenhouse is specifically designed to make the most profitable use of functional space for growers while also providing precision temperature, humidity and lighting control to ensure the production of the highest quality food grade product.
In December 2016, Greengro purchased a 20-liter supercritical CO2 extraction machine for its extraction laboratories like the one to be built on the Adelanto site. This system utilizes high-flow pumps and large capacity extraction columns to rapidly recover essential oils from the plants.
https://cannabisventuresinc.com/greengro-technologies-3-tier-franchise-model-used-develop-4-5-acre-site-licensed-cannabis-grow-adelanto-calif-cannabis-ventures-glass-greenhouse-franchises/
Canada might be going MJ recreational July 2018 will GRNH also be part of that catalyst?
Cannabis Ventures Inc has applied for a MMJ license in Sechelt, Canada and if approved, parent company Gala Global, Inc (GLAG) plans to dual-list on the Canadian Exchange.
Cannabis Ventures, Inc.
903-388 Drake Street
Vancouver, BC V6B 6A8
Canada
https://cannabisventuresinc.com/investors/
Let’s not forget the recent greenhouse purchase from LVVV.
Anaheim, CA -- October 26, 2017 -- InvestorsHub NewsWire -- LiveWire Ergogenics, Inc. (OTC: LVVV) a company focused on the acquisition and build-out of turnkey properties, product development and research partnerships for the commercialization of legal cannabinoid-based products, announced today that it has executed a lease on 4-acres of property in a commercial agriculture zoned region of Southern California, completed set-up of the Company's greenhouse and readies for production.
"Greenhouse-number-one will be operated by the horticulture experts at The Greenhouse Collect, a non-profit organization serving medical marijuana patients since 2014. They will lease the facility from LiveWire to operate their medical cannabis clone development project," said Bill Hodson, CEO of LiveWire Ergogenics. "The turnkey greenhouse was purchased from GreenGro Technologies, Inc.'s (OTC: GRNH) line of state-of-the-art, fully automated Greenhouses.
http://www.nasdaq.com/press-release/livewire-ergogenics-secures-4acre-property-for-medical-marijuana-greenhouse-facilities-20171026-01107
Below are a few good articles.
http://www.newsweek.com/medical-marijuana-cbd-not-addictive-toxic-who-says-748069
https://www.forbes.com/sites/trangho/2017/12/03/how-to-buy-marijuana-stocks-quickly-and-easily-with-this-new-fund/#65dd746b58de
https://dabconnection.com/marijuana-stocks/emerging-agrosphere-etf-the-first-cannabis-etf/
https://www.clevescene.com/scene-and-heard/archives/2017/12/11/campaign-seeks-recreational-marijuana-amendment-on-ohio-ballot-in-november-2018?media=AMP+HTML
https://finance.yahoo.com/news/gala-global-inc-announces-name-131500254.html
name change 2 hrs ago
Sorry...Meant 2017, not enough coffee at the time then I had reached the maximum posts for a "free" member so I couldn't respond. Would I be correct in thinking the shares that are restricted can't be sold until end of Jan fist of Feb?
Could be something in the works between GRNH & GLAG. GRNH tweeting about the company.
https://mobile.twitter.com/greengrotech
Looks like GLAG recently changed their name from Gala Global Inc to Gala Pharmaceuticals Inc.
https://galapharmaceuticals.com/
From their website:
To provide operational services and technologies that drive efficiencies in the greenhouse-grown commercial plants and herbs markets.
To engage in joint venture projects with academic institutions, corporations and other plant breeding industry groups.
Provide business opportunities in the areas of equity investment, debt financing and mergers and acquisitions (M&A).
Looks like GLAG & GRNH filed a provisional patent application on plant cloning technology.
https://galaglobalinc.com/press/gala-global-inc-subsidiary-controlled-environment-genomics-inc-files-provisional-patent-application-on-plant-cloning-technology/
About GenoBreeding Inc.
GenoBreeding Inc., a subsidiary of Greengro Technologies, Inc. (GRNH), Anaheim, Calif., was formed in early 2017 to direct a Greengro initiative intended to bring to the cannabis market cutting-edge plant varieties through the application of modern plant breeding technologies conducive to increased consumer demand and improved production profitability.
https://genobreeding.com
https://greengrotech.com
MJ sector has been heating up!
https://marijuanaindex.com/
I had to re-read your post and pull the filings. You are talking about the reverse that happened january of 2017, not one coming up.
I think that this deal has some legs and with a low float and managed aomunts of shares coming into it over time should do well.
Share count is low for now, but reading the latest files it appears they've been busy distributing shares, hope they run this before those shares flood the market
I didn't think of that, will start following them on FB.
Based on how long folks have to hold restricted shares and the timing of the reverse split (end of Jan16) there should be less than 5 mil shares in the market for them until end of Jan 1st of Feb, what are your thoughts?
I also have been holding, haven't been following up much, just been reading their fb page every now and then but it mirrors greengro's posts
Yep, still hanging around and hoping it gets interesting in Jan due to the restricted shares being kept out of the market. Any interesting tidbits besides the name change? Have been thinking of calling Haas but its usually hard to get him to say much. I know there was plans to start production on the cloning units in December, any mention of that or other projects?
Good to see someone still hanging around, I read about it in the 8k filed yesterday
Interesting... Are you able to elaborate? I've been in this since before the split and holding on till after first of the year, any info you can provide will be greatly appreciated.
Looks like name change to gala pharmaceuticals
This thing is thin, could get real interesting in Jan!
Down $.5199 on 100 Share Trade...At $.3501
Followers
|
47
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2024
|
Created
|
11/29/12
|
Type
|
Free
|
Moderators |
GLAG
http://www.otcmarkets.com/stock/GLAG/filings
COMPANY OVERVIEW
RECENT PR
Gala Global believes that with California medical marijuana bills AB 266, AB 243 and SB 643 having gone into effect on January 1, 2016, the State is primed to become a hemp and cannabis global economic leader. It is therefore paramount that the Company assembles the best minds and leaders from across all sectors of the industry under the Gala Global umbrella to assure a prosperous ushering into the new regulatory frameworkthat awaits.
https://finance.yahoo.com/news/gala-global-reveals-creation-specialized-130000161.html
Websites
https://cbdventures.com/
https://cannabisventuresinc.com/blog/
http://galaglobalinc.com/
https://www.facebook.com/galaglobalinc
https://www.facebook.com/pages/Cannabis-Ventures-Inc
GALA Global, Inc. is a publicly traded development stage company which plans to expand in the Hemp and Cannabis industries. The Company is refocusing its purpose on the development, research, and commercialization of products derived from Hemp and Cannabis Plant, while expanding the clothing operations and upcoming Hemp based fiber apparel and accessories division under the direction of the internationally recognized designer Paul Frank.
The new focus and direction for GALA is to stay in line with natural and eco-friendly products but allow such products to be used for multiple applications.
CBD Life a wholly owned subsidiary of Gala Global based in California currently markets new CBD flavored Thin-film strip. The Thin Film delivery uses a dissolving film strip that is absorption in the mouth. This approach rapidly dissolves directed as a systemic delivery approach. Thin-film is an advanced method to providing CBD for dietary supplement. Thin Film will provide means for the cannabidiol more bioavailable by allowing the strip dissolves immediately to enter the body. CDB — – “Innovative Healthy Living.”
http://cbdlivin.com/
Cannabis Ventures, Inc., a wholly owned subsidiary of Gala Global based in Canada currently has an application in review with Health Canada for the Marijuana for Medical Purposes Regulations (MMPR) license. Cannabis Ventures, Inc. plans to operate a cultivation facility servicing Health Canada patients upon receiving approval.
GALA Global is deploying a three part strategy to deliver solid top-line revenue, proven reserves, and better than average sector profits through cost reductions afforded by its technology and approach.
PHASE ONE. The initial phase to introduce CBD (Cannabidiol) products. The initial products will based on flavored infused CBD Oral Thin Film Strips. Gala Global’s products will feature a 10 mg Flavored CBD Oral Thin Film Strip and a 25 mg Flavored CBD Oral Thin Strip that will address the dietary supplement market. The CBD products will be scientifically formulated for maximum nutritional benefits and will produced in an FDA Certified GMP facility to ensure the repeatable high quality standards.
PHASE TWO. Introduce design and creation using Hemp and natural eco- friendly and recyclable blended materials. Product line planned to be introduced in 2015.
PHASE THREE. Cannabis Ventures, Inc will manage Cannabis cultivation operation opportunities around the Globe. The initial operations will be based in British Columbia Canada. CVI will also seek new opportunities in management contract and expertise support in government and regions approved for Cannabis operating locations.
CEO EXPERIENCE
"Calvin Frye for the past 10 years has been both a dispensary owner and an MMJ industry consultant. Mr. Frye has held several key positions in the Biotech industry for major companies like Xoma, Amgen and Baxter Biosciences, such as working his way up from Research Associate to Associate Scientist. Mr. Frye also has over a decade of experience in the cannabis industry, having worked with some of the founders of the MMJ industry (Dennis Peron and Richard Eastman) as well as many of the industry pioneering groups in Los Angeles (Americans For Safe Access and Norml). Mr. Frye has traveled the country to many (current) MMJ states on speaking engagements in order to help get MMJ legislation passed in those states. Mr. Frye has working knowledge of the regulatory issues within this industry from his experience with working with local LA government bodies and Agencies. Mr. Frye has also branded his line of cannabis genetics and trademarked the name “Cloneville” which he has attached to his genetics. In 2009, Mr. Frye consulted in hydroponics industry where he gained extensive knowledge in the actual growing, set up and production of cannabis. Mr Frye also owns Frye Consulting and Management Group, which handles consulting services from startup to full scale production, including regulatory expertise. Mr. Frye earned his Bachelor of Science degree from the University of Iowa (Big Ten Conference) in Science Education. He also attended graduate college with an emphasis in General Science."
"Allison Hess, for the past year has been President of Hssy Inc., an international business finance and operations consulting firm based out of San Diego, CA. Prior to Hssy Inc., Ms. Hess work in the legal field for more than seven years having been with to local firms from 2010 up to 2014. She is knowledgeable with regard to all levels of the courts from local Small Claims actions to federal district Court matters and is experienced in a number of commercial practice areas including corporate finance, real estate, licensing and contracts. She has helped numerous companies with their creation of a new business and the issues that arise therefrom such as public relations, government permitting and legislation, interacting with suppliers and vendors, and the public company markets. For the last several years Ms. Hess’ efforts have been focused on the legal medicinal and recreational cannabis, CBD and Industrial Hemp markets, and such knowledge will be huge benefit for Gala Global, Inc."
LOS ANGELES, CA–(June 24, 2015) – Gala Global, Inc. (OTCPK: GLAG) today announced the planned introduction on additional products through CBD Livin (www.cbdlivin.com). The products are currently in the final stages . CBD Livin will be a channel distribution to address the specialty health market and continues to look at various products that are in line with the company mission and vision for health supplement options. The planned new products in CBD Livin pipeline are CBD Life Water, CBD Life Teas and CBD Life Vape pens. The Cannabidiol (CBD) products will be derived from Hemp. The CBD products will be scientifically formulated for maximum nutritional benefits and will be produced in an FDA Certified GMP facility to ensure the repeatable high quality standards.
Gala Global provides committed strategy with our CBD products. We plan to introduce several innovated new products to the nutritional supplement market. Our CBD Livin brands will provide a healthy lifestyle nutraceutical products for consumers. The Company looks to expand its interests in distribution in the natural wellness sector and in approved MMJ States.
CBD Life Water will be an alternative oral delivery system which allows patient compliance due to the ease of administration and daily use. The additional advantages helps with proper administration in geriatric and pediatric where swallowing is an issue. Water is a daily necessity for our healthy living and having CBD infusion creates additional value to our dietary supplement.
Drew Milburn, CEO states, “We are planning an aggressive marketing strategy for our new pipeline for CBD infused products under the CBD Livin brand. CDB Livin division will address the demands in the approved Cannabis States that regulate dispensaries. We will focus our immediate marketing strategy in approved medicinal Cannabis States including CO, AZ, WA, NV and OR along with the dispensaries in CA. CBD Livin products with Cannabidiol infused dietary supplement products is the continued company’s mission to make CBD available to customers. Gala Global’s CBD Livin is poised to position itself to be a key player in standardizing CBD products for consumers daily nutritional diet with ease of use.”
Charles Houghton, Esq. to Lead Gala Global Attain Hemp License and Operating Location in Colorado |
Legal Industry Expert on Hemp and Cannabis to Join Gala Global, Inc. Board of Directors LOS ANGELES, CA / ACCESSWIRE / May 13, 2015 / Gala Global, Inc. (PINKSHEETS: GLAG) today announced that Charles T. Houghton, Esq joins the Board of Directors of Gala Global, Inc. Mr. Houghton will also take the lead for Gala Global to attain a Hemp cultivation license in Colorado. Mr. Houghton is a licensed attorney with over 29 years' experience and is dedicated to providing business, compliance, licensing and regulatory advice to the hemp and cannabis industries. Mr. Houghton provides expertise in regulatory compliance matters, business law, municipal law, real estate, commercial leasing, zoning, planning, construction and litigation. Prior to joining Gala Global, Inc., Mr. Houghton sat on the City of Colorado Springs Medical Marijuana Task Force to help the City of Colorado Springs, Colorado, the second largest metropolitan area in the State of Colorado, develop its regulatory framework and has testified before the State House and Senate regarding marijuana businesses. Mr. Houghton helped the city establish regulations around medical marijuana sales. Mr. Houghton also co-founded the Marijuana Business Academy, which helps entrepreneurs, established businesses and investors find success in the marketplace. Mr. Houghton stated, "I am excited to lead Gala Global in attaining a Hemp cultivation license and setting up operations along with other opportunities worldwide. This new business interest will generate tax dollars, while creating jobs and new employment opportunities. Our firm's specialty is to identify unmet opportunities with creative business people. My involvement with Gala Global is to help expand our current ventures both nationally and internationally. "We are excited to have Mr. Houghton's involvement with Gala Global's vision. This Hemp license opportunity allows Gala Global to become more vertically integrated providing more control over the high quality of our source supply Cannabidiol (CBD). I look forward to his enthusiastic involvement as we build our operations," stated CEO Drew Milburn. |
Gala Global to introduce Flavored Oral Thin Film “CBD” Products
LOS ANGELES, CA–( February 11, 2015) – Gala Global, Inc. (OTCQB: GLAG) today announced it has finalized the initial CBD products. The initial products will based on flavored infused CBD Oral Thin Film Strips. Gala Global’s products will feature a 13 mg Flavored CBD Oral Thin Film Strip and a 25 mg Flavored CBD Oral Thin Strip that will address the dietary supplement market. The CBD products will be scientifically formulated for maximum nutritional benefits and will produced in an FDA Certified GMP facility to ensure the repeatable high quality standards. The products will be finalized and ready for market introduction upon analytical testing to be completed.
Thin-film drug delivery uses a dissolving film strip that is absorption in the mouth. This approach rapidly dissolves directed as a systemic delivery approach. Thin-film is an advanced method to providing CBD for dietary supplement. Thin Film will provide means for the cannabidiol more bioavailable by allowing the strip dissolves immediately to enter the body.
George R. Lefevre, CEO stated, “We pleased to finalize the product development for our CBD line of dietary supplements. The Company is at an important milestone for Gala Global in launching our CBD infused dietary supplement products. This is a historical benchmark in the company plans to make available products with the natural healing properties from CBD. CBD has known to relieving symptoms wide range of critical conditions, including: rheumatoid arthritis, diabetes, alcoholism, PTSD, epilepsy, antibiotic-resistant infections, neurological disorders, and muscular dystrophy, pain and physiological disorders. ”
Gala Global nutraceutical division will address the demands in the global dietary supplements market which is targeted to reach beyond $200 billion. The supplement, wellness and the personal healthcare products will become launched in a new division focused for the Company’s CBD based products.
LOS ANGELES, May 7, 2015 (GLOBE NEWSWIRE) -- Gala Global, Inc. (OTCPK:GLAG) is pleased to announce industry expert Mr. Drew Milburn as Gala Global's new CEO. Mr. Milburn has been a leader in the Cannabis and Hemp sector with focus in Cannabidiol since 2005. Mr. Milburn has developed manufacturing plans that helped ensure the controlled and continuous production of high quality medical cannabis and hemp. Mr. Milburn also started We Grow Colorado, which was the first medical marijuana operation licensed in Colorado Springs in 2010. This new management brings over a decade of experience in evaluation, knowledge management and learning that will position Gala Global to the next level.
Mr. Drew Milburn is well positioned to lead Gala Global into the future with his unique combination of technical knowledge and successful track record of commercial development field expertise. Mr. Milburn's leadership was originally formed as a decorated former United States Marine who provided 12 years service as a logistic specialist. His professionalism and expertise in Cannabidiol makes him a logical and perfect choice to bring Gala Global to the forefront as industry leader in this specialty sector.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |